Packaging Biologic Drugs for Clinical Trials

Contract packaging organizations for clinical trial materials are increasingly handling biologic drugs, which are typically delivered by injection and have more stringent packaging requirements than other drug forms. In addition to the shift to biologics, the trend to direct-to-patient shipping affects how materials are packaged and makes tracking even more important. Careful consideration of primary packaging materials, kit design, and distribution is crucial for optimizing packages that balance user requirements, protection of drug product quality, and efficiency.

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.

About the Author

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 44–48

Citation

When referring to this article, please cite it as J. Markarian, “Packaging Biologic Drugs for Clinical Trials" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).